Fig. 3
From: MiR-106a directly targets LIMK1 to inhibit proliferation and EMT of oral carcinoma cells
LIMK1 is a direct target of miR-106a. SCC4 cells were transfected with an miR-106a mimic or inhibitor for 48 h. a Schematic representation of LIMK1 3’UTRs showing the putative miRNA target site. b The analysis of the relative luciferase activities of LIMK1-WT and LIMK1-MUT. c The mRNA and protein expressions of LIMK1 were determined via quantitative RT-PCR and western blot, respectively. All data are presented as means ± SEM, n = 6. ##p < 0.01, ###p < 0.001 vs. miR-NC or anti-miR-NC